This study aimed to optimize an injectable carbonated hydroxyapatite cement for metaphyseal bone defect filling and to evaluate its biomechanical performance in distal radius fracture fixation. Six food- or pharmaceutical-grade additives, including sodium alginate, glycerol, astragalus gum, xanthan gum, citric acid, and hydroxypropyl methylcellulose (HPMC), were screened to improve injectability while maintaining setting behavior and mechanical strength. Among them, 2% HPMC provided the best overall performance, increasing injectability to approximately 95% without markedly affecting setting time or compressive strength. The optimized injectable carbonated hydroxyapatite cement (ICHA) was then tested in a standardized human cadaveric distal radius fracture-defect model using three fixation strategies: K-wire fixation alone, ICHA cement alone, and combined ICHA + K-wire fixation. Within a 10 degrees torsion range, the ICHA and ICHA + K-wire groups showed higher torsional stiffness and maximum torque than the K-wire-only group, although peak torque occurred at smaller torsion angles. Under physiological compression, the groups showed comparable stability, whereas ICHA-containing groups showed greater resistance under higher compression. These findings suggest that 2% HPMC-modified ICHA may serve as an injectable metaphyseal void filler and structural adjunct to conventional K-wire fixation.